Epigenetic silencing of CHD5, a novel tumor‐suppressor gene, occurs in early colorectal cancer stages

E-ISSN： 1097-0142|120|2|172-180

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.2, 2014-01, pp. : 172-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Osteopontin Levels in Metastatic Melanoma Correlate with Epigenetic Silencing of Breast Cancer Metastasis Suppressor 1

Oncology, Vol. 78, Iss. 1, 2010-03 ,pp. : 75-86

Karger

Access to resources Recommend Favorite

Epigenetic inactivation of transforming growth factor‐β1 target gene HEYL, a novel tumor suppressor, is involved in the P53‐induced apoptotic pathway in hepatocellular carcinoma

HEPATOLOGY RESEARCH, Vol. 45, Iss. 7, 2015-07 ,pp. : 782-793

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Tumor Suppressor Gene TP53: Implications for Cancer Management and Therapy

By Seemann Séverine Maurici Daniela Olivier Magali Fromentel Claude Hainaut Pierre

Critical Reviews in Clinical Laboratory Sciences, Vol. 41, Iss. 5-6, 2004-09 ,pp. : 551-583

Informa Healthcare

Access to resources Recommend Favorite

Chemoresistance of Cancer Cells: Oncogenic Mutation of the p53 Tumor Suppressor Gene

Current Signal Transduction Therapy, Vol. 11, Iss. 1, 2016-04 ,pp. : 3-8

Bentham Science Publishers

Access to resources Recommend Favorite

Staging of Primary Breast Cancer Is not Indicated in Asymptomatic Patients with Early Tumor Stages

Oncology Research and Treatment, Vol. 37, Iss. 7-8, 2014-05 ,pp. : 400-405

Karger

Access to resources Recommend Favorite